Global Biopharmaceutical CMO and CRO Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Biopharmaceutical CMO and CRO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biopharmaceutical CMO and CRO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biopharmaceutical CMO and CRO market in any manner.
Global Biopharmaceutical CMO and CRO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AGC Biologics
Boehringer Ingelheim International GmbH
FUJIFILM Diosynth Biotechnologies
Inno Bio Ventures Sdn Bhd
JRS PHARMA
Lonza
PRA Health Sciences, Inc.
ProBioGen AG
Rentschler Biopharma SE
Samsung BioLogics
Market Segmentation (by Type)
Contract Manufacturing
Contract Research
Market Segmentation (by Application)
Biologics Manuefacturing
Biosimilars Manuefacturing
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biopharmaceutical CMO and CRO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Biopharmaceutical CMO and CRO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biopharmaceutical CMO and CRO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biopharmaceutical CMO and CRO market in any manner.
Global Biopharmaceutical CMO and CRO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AGC Biologics
Boehringer Ingelheim International GmbH
FUJIFILM Diosynth Biotechnologies
Inno Bio Ventures Sdn Bhd
JRS PHARMA
Lonza
PRA Health Sciences, Inc.
ProBioGen AG
Rentschler Biopharma SE
Samsung BioLogics
Market Segmentation (by Type)
Contract Manufacturing
Contract Research
Market Segmentation (by Application)
Biologics Manuefacturing
Biosimilars Manuefacturing
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biopharmaceutical CMO and CRO Market
- Overview of the regional outlook of the Biopharmaceutical CMO and CRO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biopharmaceutical CMO and CRO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biopharmaceutical CMO and CRO
1.2 Key Market Segments
1.2.1 Biopharmaceutical CMO and CRO Segment by Type
1.2.2 Biopharmaceutical CMO and CRO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOPHARMACEUTICAL CMO AND CRO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biopharmaceutical CMO and CRO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biopharmaceutical CMO and CRO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOPHARMACEUTICAL CMO AND CRO MARKET COMPETITIVE LANDSCAPE
3.1 Global Biopharmaceutical CMO and CRO Sales by Manufacturers (2019-2024)
3.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Manufacturers (2019-2024)
3.3 Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biopharmaceutical CMO and CRO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biopharmaceutical CMO and CRO Sales Sites, Area Served, Product Type
3.6 Biopharmaceutical CMO and CRO Market Competitive Situation and Trends
3.6.1 Biopharmaceutical CMO and CRO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biopharmaceutical CMO and CRO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CMO AND CRO INDUSTRY CHAIN ANALYSIS
4.1 Biopharmaceutical CMO and CRO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOPHARMACEUTICAL CMO AND CRO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOPHARMACEUTICAL CMO AND CRO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biopharmaceutical CMO and CRO Sales Market Share by Type (2019-2024)
6.3 Global Biopharmaceutical CMO and CRO Market Size Market Share by Type (2019-2024)
6.4 Global Biopharmaceutical CMO and CRO Price by Type (2019-2024)
7 BIOPHARMACEUTICAL CMO AND CRO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biopharmaceutical CMO and CRO Market Sales by Application (2019-2024)
7.3 Global Biopharmaceutical CMO and CRO Market Size (M USD) by Application (2019-2024)
7.4 Global Biopharmaceutical CMO and CRO Sales Growth Rate by Application (2019-2024)
8 BIOPHARMACEUTICAL CMO AND CRO MARKET SEGMENTATION BY REGION
8.1 Global Biopharmaceutical CMO and CRO Sales by Region
8.1.1 Global Biopharmaceutical CMO and CRO Sales by Region
8.1.2 Global Biopharmaceutical CMO and CRO Sales Market Share by Region
8.2 North America
8.2.1 North America Biopharmaceutical CMO and CRO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biopharmaceutical CMO and CRO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biopharmaceutical CMO and CRO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biopharmaceutical CMO and CRO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biopharmaceutical CMO and CRO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AGC Biologics
9.1.1 AGC Biologics Biopharmaceutical CMO and CRO Basic Information
9.1.2 AGC Biologics Biopharmaceutical CMO and CRO Product Overview
9.1.3 AGC Biologics Biopharmaceutical CMO and CRO Product Market Performance
9.1.4 AGC Biologics Business Overview
9.1.5 AGC Biologics Biopharmaceutical CMO and CRO SWOT Analysis
9.1.6 AGC Biologics Recent Developments
9.2 Boehringer Ingelheim International GmbH
9.2.1 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Basic Information
9.2.2 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Overview
9.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Market Performance
9.2.4 Boehringer Ingelheim International GmbH Business Overview
9.2.5 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO SWOT Analysis
9.2.6 Boehringer Ingelheim International GmbH Recent Developments
9.3 FUJIFILM Diosynth Biotechnologies
9.3.1 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Basic Information
9.3.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Overview
9.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Market Performance
9.3.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO SWOT Analysis
9.3.5 FUJIFILM Diosynth Biotechnologies Business Overview
9.3.6 FUJIFILM Diosynth Biotechnologies Recent Developments
9.4 Inno Bio Ventures Sdn Bhd
9.4.1 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Basic Information
9.4.2 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Overview
9.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Market Performance
9.4.4 Inno Bio Ventures Sdn Bhd Business Overview
9.4.5 Inno Bio Ventures Sdn Bhd Recent Developments
9.5 JRS PHARMA
9.5.1 JRS PHARMA Biopharmaceutical CMO and CRO Basic Information
9.5.2 JRS PHARMA Biopharmaceutical CMO and CRO Product Overview
9.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Product Market Performance
9.5.4 JRS PHARMA Business Overview
9.5.5 JRS PHARMA Recent Developments
9.6 Lonza
9.6.1 Lonza Biopharmaceutical CMO and CRO Basic Information
9.6.2 Lonza Biopharmaceutical CMO and CRO Product Overview
9.6.3 Lonza Biopharmaceutical CMO and CRO Product Market Performance
9.6.4 Lonza Business Overview
9.6.5 Lonza Recent Developments
9.7 PRA Health Sciences, Inc.
9.7.1 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Basic Information
9.7.2 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Overview
9.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Market Performance
9.7.4 PRA Health Sciences, Inc. Business Overview
9.7.5 PRA Health Sciences, Inc. Recent Developments
9.8 ProBioGen AG
9.8.1 ProBioGen AG Biopharmaceutical CMO and CRO Basic Information
9.8.2 ProBioGen AG Biopharmaceutical CMO and CRO Product Overview
9.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Product Market Performance
9.8.4 ProBioGen AG Business Overview
9.8.5 ProBioGen AG Recent Developments
9.9 Rentschler Biopharma SE
9.9.1 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Basic Information
9.9.2 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Overview
9.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Market Performance
9.9.4 Rentschler Biopharma SE Business Overview
9.9.5 Rentschler Biopharma SE Recent Developments
9.10 Samsung BioLogics
9.10.1 Samsung BioLogics Biopharmaceutical CMO and CRO Basic Information
9.10.2 Samsung BioLogics Biopharmaceutical CMO and CRO Product Overview
9.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Product Market Performance
9.10.4 Samsung BioLogics Business Overview
9.10.5 Samsung BioLogics Recent Developments
10 BIOPHARMACEUTICAL CMO AND CRO MARKET FORECAST BY REGION
10.1 Global Biopharmaceutical CMO and CRO Market Size Forecast
10.2 Global Biopharmaceutical CMO and CRO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biopharmaceutical CMO and CRO Market Size Forecast by Country
10.2.3 Asia Pacific Biopharmaceutical CMO and CRO Market Size Forecast by Region
10.2.4 South America Biopharmaceutical CMO and CRO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biopharmaceutical CMO and CRO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biopharmaceutical CMO and CRO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biopharmaceutical CMO and CRO by Type (2025-2030)
11.1.2 Global Biopharmaceutical CMO and CRO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biopharmaceutical CMO and CRO by Type (2025-2030)
11.2 Global Biopharmaceutical CMO and CRO Market Forecast by Application (2025-2030)
11.2.1 Global Biopharmaceutical CMO and CRO Sales (K Units) Forecast by Application
11.2.2 Global Biopharmaceutical CMO and CRO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biopharmaceutical CMO and CRO
1.2 Key Market Segments
1.2.1 Biopharmaceutical CMO and CRO Segment by Type
1.2.2 Biopharmaceutical CMO and CRO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOPHARMACEUTICAL CMO AND CRO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biopharmaceutical CMO and CRO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biopharmaceutical CMO and CRO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOPHARMACEUTICAL CMO AND CRO MARKET COMPETITIVE LANDSCAPE
3.1 Global Biopharmaceutical CMO and CRO Sales by Manufacturers (2019-2024)
3.2 Global Biopharmaceutical CMO and CRO Revenue Market Share by Manufacturers (2019-2024)
3.3 Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biopharmaceutical CMO and CRO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biopharmaceutical CMO and CRO Sales Sites, Area Served, Product Type
3.6 Biopharmaceutical CMO and CRO Market Competitive Situation and Trends
3.6.1 Biopharmaceutical CMO and CRO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biopharmaceutical CMO and CRO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOPHARMACEUTICAL CMO AND CRO INDUSTRY CHAIN ANALYSIS
4.1 Biopharmaceutical CMO and CRO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOPHARMACEUTICAL CMO AND CRO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOPHARMACEUTICAL CMO AND CRO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biopharmaceutical CMO and CRO Sales Market Share by Type (2019-2024)
6.3 Global Biopharmaceutical CMO and CRO Market Size Market Share by Type (2019-2024)
6.4 Global Biopharmaceutical CMO and CRO Price by Type (2019-2024)
7 BIOPHARMACEUTICAL CMO AND CRO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biopharmaceutical CMO and CRO Market Sales by Application (2019-2024)
7.3 Global Biopharmaceutical CMO and CRO Market Size (M USD) by Application (2019-2024)
7.4 Global Biopharmaceutical CMO and CRO Sales Growth Rate by Application (2019-2024)
8 BIOPHARMACEUTICAL CMO AND CRO MARKET SEGMENTATION BY REGION
8.1 Global Biopharmaceutical CMO and CRO Sales by Region
8.1.1 Global Biopharmaceutical CMO and CRO Sales by Region
8.1.2 Global Biopharmaceutical CMO and CRO Sales Market Share by Region
8.2 North America
8.2.1 North America Biopharmaceutical CMO and CRO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biopharmaceutical CMO and CRO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biopharmaceutical CMO and CRO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biopharmaceutical CMO and CRO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biopharmaceutical CMO and CRO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AGC Biologics
9.1.1 AGC Biologics Biopharmaceutical CMO and CRO Basic Information
9.1.2 AGC Biologics Biopharmaceutical CMO and CRO Product Overview
9.1.3 AGC Biologics Biopharmaceutical CMO and CRO Product Market Performance
9.1.4 AGC Biologics Business Overview
9.1.5 AGC Biologics Biopharmaceutical CMO and CRO SWOT Analysis
9.1.6 AGC Biologics Recent Developments
9.2 Boehringer Ingelheim International GmbH
9.2.1 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Basic Information
9.2.2 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Overview
9.2.3 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Market Performance
9.2.4 Boehringer Ingelheim International GmbH Business Overview
9.2.5 Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO SWOT Analysis
9.2.6 Boehringer Ingelheim International GmbH Recent Developments
9.3 FUJIFILM Diosynth Biotechnologies
9.3.1 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Basic Information
9.3.2 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Overview
9.3.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Market Performance
9.3.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO SWOT Analysis
9.3.5 FUJIFILM Diosynth Biotechnologies Business Overview
9.3.6 FUJIFILM Diosynth Biotechnologies Recent Developments
9.4 Inno Bio Ventures Sdn Bhd
9.4.1 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Basic Information
9.4.2 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Overview
9.4.3 Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Market Performance
9.4.4 Inno Bio Ventures Sdn Bhd Business Overview
9.4.5 Inno Bio Ventures Sdn Bhd Recent Developments
9.5 JRS PHARMA
9.5.1 JRS PHARMA Biopharmaceutical CMO and CRO Basic Information
9.5.2 JRS PHARMA Biopharmaceutical CMO and CRO Product Overview
9.5.3 JRS PHARMA Biopharmaceutical CMO and CRO Product Market Performance
9.5.4 JRS PHARMA Business Overview
9.5.5 JRS PHARMA Recent Developments
9.6 Lonza
9.6.1 Lonza Biopharmaceutical CMO and CRO Basic Information
9.6.2 Lonza Biopharmaceutical CMO and CRO Product Overview
9.6.3 Lonza Biopharmaceutical CMO and CRO Product Market Performance
9.6.4 Lonza Business Overview
9.6.5 Lonza Recent Developments
9.7 PRA Health Sciences, Inc.
9.7.1 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Basic Information
9.7.2 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Overview
9.7.3 PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Market Performance
9.7.4 PRA Health Sciences, Inc. Business Overview
9.7.5 PRA Health Sciences, Inc. Recent Developments
9.8 ProBioGen AG
9.8.1 ProBioGen AG Biopharmaceutical CMO and CRO Basic Information
9.8.2 ProBioGen AG Biopharmaceutical CMO and CRO Product Overview
9.8.3 ProBioGen AG Biopharmaceutical CMO and CRO Product Market Performance
9.8.4 ProBioGen AG Business Overview
9.8.5 ProBioGen AG Recent Developments
9.9 Rentschler Biopharma SE
9.9.1 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Basic Information
9.9.2 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Overview
9.9.3 Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Market Performance
9.9.4 Rentschler Biopharma SE Business Overview
9.9.5 Rentschler Biopharma SE Recent Developments
9.10 Samsung BioLogics
9.10.1 Samsung BioLogics Biopharmaceutical CMO and CRO Basic Information
9.10.2 Samsung BioLogics Biopharmaceutical CMO and CRO Product Overview
9.10.3 Samsung BioLogics Biopharmaceutical CMO and CRO Product Market Performance
9.10.4 Samsung BioLogics Business Overview
9.10.5 Samsung BioLogics Recent Developments
10 BIOPHARMACEUTICAL CMO AND CRO MARKET FORECAST BY REGION
10.1 Global Biopharmaceutical CMO and CRO Market Size Forecast
10.2 Global Biopharmaceutical CMO and CRO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biopharmaceutical CMO and CRO Market Size Forecast by Country
10.2.3 Asia Pacific Biopharmaceutical CMO and CRO Market Size Forecast by Region
10.2.4 South America Biopharmaceutical CMO and CRO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biopharmaceutical CMO and CRO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biopharmaceutical CMO and CRO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biopharmaceutical CMO and CRO by Type (2025-2030)
11.1.2 Global Biopharmaceutical CMO and CRO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biopharmaceutical CMO and CRO by Type (2025-2030)
11.2 Global Biopharmaceutical CMO and CRO Market Forecast by Application (2025-2030)
11.2.1 Global Biopharmaceutical CMO and CRO Sales (K Units) Forecast by Application
11.2.2 Global Biopharmaceutical CMO and CRO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biopharmaceutical CMO and CRO Market Size Comparison by Region (M USD)
Table 5. Global Biopharmaceutical CMO and CRO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biopharmaceutical CMO and CRO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biopharmaceutical CMO and CRO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biopharmaceutical CMO and CRO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2022)
Table 10. Global Market Biopharmaceutical CMO and CRO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biopharmaceutical CMO and CRO Sales Sites and Area Served
Table 12. Manufacturers Biopharmaceutical CMO and CRO Product Type
Table 13. Global Biopharmaceutical CMO and CRO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biopharmaceutical CMO and CRO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biopharmaceutical CMO and CRO Market Challenges
Table 22. Global Biopharmaceutical CMO and CRO Sales by Type (K Units)
Table 23. Global Biopharmaceutical CMO and CRO Market Size by Type (M USD)
Table 24. Global Biopharmaceutical CMO and CRO Sales (K Units) by Type (2019-2024)
Table 25. Global Biopharmaceutical CMO and CRO Sales Market Share by Type (2019-2024)
Table 26. Global Biopharmaceutical CMO and CRO Market Size (M USD) by Type (2019-2024)
Table 27. Global Biopharmaceutical CMO and CRO Market Size Share by Type (2019-2024)
Table 28. Global Biopharmaceutical CMO and CRO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biopharmaceutical CMO and CRO Sales (K Units) by Application
Table 30. Global Biopharmaceutical CMO and CRO Market Size by Application
Table 31. Global Biopharmaceutical CMO and CRO Sales by Application (2019-2024) & (K Units)
Table 32. Global Biopharmaceutical CMO and CRO Sales Market Share by Application (2019-2024)
Table 33. Global Biopharmaceutical CMO and CRO Sales by Application (2019-2024) & (M USD)
Table 34. Global Biopharmaceutical CMO and CRO Market Share by Application (2019-2024)
Table 35. Global Biopharmaceutical CMO and CRO Sales Growth Rate by Application (2019-2024)
Table 36. Global Biopharmaceutical CMO and CRO Sales by Region (2019-2024) & (K Units)
Table 37. Global Biopharmaceutical CMO and CRO Sales Market Share by Region (2019-2024)
Table 38. North America Biopharmaceutical CMO and CRO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biopharmaceutical CMO and CRO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biopharmaceutical CMO and CRO Sales by Region (2019-2024) & (K Units)
Table 41. South America Biopharmaceutical CMO and CRO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biopharmaceutical CMO and CRO Sales by Region (2019-2024) & (K Units)
Table 43. AGC Biologics Biopharmaceutical CMO and CRO Basic Information
Table 44. AGC Biologics Biopharmaceutical CMO and CRO Product Overview
Table 45. AGC Biologics Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AGC Biologics Business Overview
Table 47. AGC Biologics Biopharmaceutical CMO and CRO SWOT Analysis
Table 48. AGC Biologics Recent Developments
Table 49. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Basic Information
Table 50. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Overview
Table 51. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Boehringer Ingelheim International GmbH Business Overview
Table 53. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO SWOT Analysis
Table 54. Boehringer Ingelheim International GmbH Recent Developments
Table 55. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Basic Information
Table 56. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Overview
Table 57. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO SWOT Analysis
Table 59. FUJIFILM Diosynth Biotechnologies Business Overview
Table 60. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 61. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Basic Information
Table 62. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Overview
Table 63. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Inno Bio Ventures Sdn Bhd Business Overview
Table 65. Inno Bio Ventures Sdn Bhd Recent Developments
Table 66. JRS PHARMA Biopharmaceutical CMO and CRO Basic Information
Table 67. JRS PHARMA Biopharmaceutical CMO and CRO Product Overview
Table 68. JRS PHARMA Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. JRS PHARMA Business Overview
Table 70. JRS PHARMA Recent Developments
Table 71. Lonza Biopharmaceutical CMO and CRO Basic Information
Table 72. Lonza Biopharmaceutical CMO and CRO Product Overview
Table 73. Lonza Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lonza Business Overview
Table 75. Lonza Recent Developments
Table 76. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Basic Information
Table 77. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Overview
Table 78. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. PRA Health Sciences, Inc. Business Overview
Table 80. PRA Health Sciences, Inc. Recent Developments
Table 81. ProBioGen AG Biopharmaceutical CMO and CRO Basic Information
Table 82. ProBioGen AG Biopharmaceutical CMO and CRO Product Overview
Table 83. ProBioGen AG Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. ProBioGen AG Business Overview
Table 85. ProBioGen AG Recent Developments
Table 86. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Basic Information
Table 87. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Overview
Table 88. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Rentschler Biopharma SE Business Overview
Table 90. Rentschler Biopharma SE Recent Developments
Table 91. Samsung BioLogics Biopharmaceutical CMO and CRO Basic Information
Table 92. Samsung BioLogics Biopharmaceutical CMO and CRO Product Overview
Table 93. Samsung BioLogics Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Samsung BioLogics Business Overview
Table 95. Samsung BioLogics Recent Developments
Table 96. Global Biopharmaceutical CMO and CRO Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Biopharmaceutical CMO and CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Biopharmaceutical CMO and CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Biopharmaceutical CMO and CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Biopharmaceutical CMO and CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Biopharmaceutical CMO and CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Biopharmaceutical CMO and CRO Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Biopharmaceutical CMO and CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Biopharmaceutical CMO and CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Biopharmaceutical CMO and CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Biopharmaceutical CMO and CRO Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Biopharmaceutical CMO and CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Biopharmaceutical CMO and CRO Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Biopharmaceutical CMO and CRO Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Biopharmaceutical CMO and CRO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Biopharmaceutical CMO and CRO Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Biopharmaceutical CMO and CRO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biopharmaceutical CMO and CRO Market Size Comparison by Region (M USD)
Table 5. Global Biopharmaceutical CMO and CRO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biopharmaceutical CMO and CRO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biopharmaceutical CMO and CRO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biopharmaceutical CMO and CRO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CMO and CRO as of 2022)
Table 10. Global Market Biopharmaceutical CMO and CRO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biopharmaceutical CMO and CRO Sales Sites and Area Served
Table 12. Manufacturers Biopharmaceutical CMO and CRO Product Type
Table 13. Global Biopharmaceutical CMO and CRO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biopharmaceutical CMO and CRO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biopharmaceutical CMO and CRO Market Challenges
Table 22. Global Biopharmaceutical CMO and CRO Sales by Type (K Units)
Table 23. Global Biopharmaceutical CMO and CRO Market Size by Type (M USD)
Table 24. Global Biopharmaceutical CMO and CRO Sales (K Units) by Type (2019-2024)
Table 25. Global Biopharmaceutical CMO and CRO Sales Market Share by Type (2019-2024)
Table 26. Global Biopharmaceutical CMO and CRO Market Size (M USD) by Type (2019-2024)
Table 27. Global Biopharmaceutical CMO and CRO Market Size Share by Type (2019-2024)
Table 28. Global Biopharmaceutical CMO and CRO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biopharmaceutical CMO and CRO Sales (K Units) by Application
Table 30. Global Biopharmaceutical CMO and CRO Market Size by Application
Table 31. Global Biopharmaceutical CMO and CRO Sales by Application (2019-2024) & (K Units)
Table 32. Global Biopharmaceutical CMO and CRO Sales Market Share by Application (2019-2024)
Table 33. Global Biopharmaceutical CMO and CRO Sales by Application (2019-2024) & (M USD)
Table 34. Global Biopharmaceutical CMO and CRO Market Share by Application (2019-2024)
Table 35. Global Biopharmaceutical CMO and CRO Sales Growth Rate by Application (2019-2024)
Table 36. Global Biopharmaceutical CMO and CRO Sales by Region (2019-2024) & (K Units)
Table 37. Global Biopharmaceutical CMO and CRO Sales Market Share by Region (2019-2024)
Table 38. North America Biopharmaceutical CMO and CRO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biopharmaceutical CMO and CRO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biopharmaceutical CMO and CRO Sales by Region (2019-2024) & (K Units)
Table 41. South America Biopharmaceutical CMO and CRO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biopharmaceutical CMO and CRO Sales by Region (2019-2024) & (K Units)
Table 43. AGC Biologics Biopharmaceutical CMO and CRO Basic Information
Table 44. AGC Biologics Biopharmaceutical CMO and CRO Product Overview
Table 45. AGC Biologics Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AGC Biologics Business Overview
Table 47. AGC Biologics Biopharmaceutical CMO and CRO SWOT Analysis
Table 48. AGC Biologics Recent Developments
Table 49. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Basic Information
Table 50. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Product Overview
Table 51. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Boehringer Ingelheim International GmbH Business Overview
Table 53. Boehringer Ingelheim International GmbH Biopharmaceutical CMO and CRO SWOT Analysis
Table 54. Boehringer Ingelheim International GmbH Recent Developments
Table 55. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Basic Information
Table 56. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Product Overview
Table 57. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CMO and CRO SWOT Analysis
Table 59. FUJIFILM Diosynth Biotechnologies Business Overview
Table 60. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 61. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Basic Information
Table 62. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Product Overview
Table 63. Inno Bio Ventures Sdn Bhd Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Inno Bio Ventures Sdn Bhd Business Overview
Table 65. Inno Bio Ventures Sdn Bhd Recent Developments
Table 66. JRS PHARMA Biopharmaceutical CMO and CRO Basic Information
Table 67. JRS PHARMA Biopharmaceutical CMO and CRO Product Overview
Table 68. JRS PHARMA Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. JRS PHARMA Business Overview
Table 70. JRS PHARMA Recent Developments
Table 71. Lonza Biopharmaceutical CMO and CRO Basic Information
Table 72. Lonza Biopharmaceutical CMO and CRO Product Overview
Table 73. Lonza Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lonza Business Overview
Table 75. Lonza Recent Developments
Table 76. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Basic Information
Table 77. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Product Overview
Table 78. PRA Health Sciences, Inc. Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. PRA Health Sciences, Inc. Business Overview
Table 80. PRA Health Sciences, Inc. Recent Developments
Table 81. ProBioGen AG Biopharmaceutical CMO and CRO Basic Information
Table 82. ProBioGen AG Biopharmaceutical CMO and CRO Product Overview
Table 83. ProBioGen AG Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. ProBioGen AG Business Overview
Table 85. ProBioGen AG Recent Developments
Table 86. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Basic Information
Table 87. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Product Overview
Table 88. Rentschler Biopharma SE Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Rentschler Biopharma SE Business Overview
Table 90. Rentschler Biopharma SE Recent Developments
Table 91. Samsung BioLogics Biopharmaceutical CMO and CRO Basic Information
Table 92. Samsung BioLogics Biopharmaceutical CMO and CRO Product Overview
Table 93. Samsung BioLogics Biopharmaceutical CMO and CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Samsung BioLogics Business Overview
Table 95. Samsung BioLogics Recent Developments
Table 96. Global Biopharmaceutical CMO and CRO Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Biopharmaceutical CMO and CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Biopharmaceutical CMO and CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Biopharmaceutical CMO and CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Biopharmaceutical CMO and CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Biopharmaceutical CMO and CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Biopharmaceutical CMO and CRO Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Biopharmaceutical CMO and CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Biopharmaceutical CMO and CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Biopharmaceutical CMO and CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Biopharmaceutical CMO and CRO Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Biopharmaceutical CMO and CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Biopharmaceutical CMO and CRO Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Biopharmaceutical CMO and CRO Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Biopharmaceutical CMO and CRO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Biopharmaceutical CMO and CRO Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Biopharmaceutical CMO and CRO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biopharmaceutical CMO and CRO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biopharmaceutical CMO and CRO Market Size (M USD), 2019-2030
Figure 5. Global Biopharmaceutical CMO and CRO Market Size (M USD) (2019-2030)
Figure 6. Global Biopharmaceutical CMO and CRO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biopharmaceutical CMO and CRO Market Size by Country (M USD)
Figure 11. Biopharmaceutical CMO and CRO Sales Share by Manufacturers in 2023
Figure 12. Global Biopharmaceutical CMO and CRO Revenue Share by Manufacturers in 2023
Figure 13. Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biopharmaceutical CMO and CRO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biopharmaceutical CMO and CRO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biopharmaceutical CMO and CRO Market Share by Type
Figure 18. Sales Market Share of Biopharmaceutical CMO and CRO by Type (2019-2024)
Figure 19. Sales Market Share of Biopharmaceutical CMO and CRO by Type in 2023
Figure 20. Market Size Share of Biopharmaceutical CMO and CRO by Type (2019-2024)
Figure 21. Market Size Market Share of Biopharmaceutical CMO and CRO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biopharmaceutical CMO and CRO Market Share by Application
Figure 24. Global Biopharmaceutical CMO and CRO Sales Market Share by Application (2019-2024)
Figure 25. Global Biopharmaceutical CMO and CRO Sales Market Share by Application in 2023
Figure 26. Global Biopharmaceutical CMO and CRO Market Share by Application (2019-2024)
Figure 27. Global Biopharmaceutical CMO and CRO Market Share by Application in 2023
Figure 28. Global Biopharmaceutical CMO and CRO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biopharmaceutical CMO and CRO Sales Market Share by Region (2019-2024)
Figure 30. North America Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biopharmaceutical CMO and CRO Sales Market Share by Country in 2023
Figure 32. U.S. Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biopharmaceutical CMO and CRO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biopharmaceutical CMO and CRO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biopharmaceutical CMO and CRO Sales Market Share by Country in 2023
Figure 37. Germany Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biopharmaceutical CMO and CRO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biopharmaceutical CMO and CRO Sales Market Share by Region in 2023
Figure 44. China Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biopharmaceutical CMO and CRO Sales and Growth Rate (K Units)
Figure 50. South America Biopharmaceutical CMO and CRO Sales Market Share by Country in 2023
Figure 51. Brazil Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biopharmaceutical CMO and CRO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biopharmaceutical CMO and CRO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biopharmaceutical CMO and CRO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biopharmaceutical CMO and CRO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biopharmaceutical CMO and CRO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biopharmaceutical CMO and CRO Market Share Forecast by Type (2025-2030)
Figure 65. Global Biopharmaceutical CMO and CRO Sales Forecast by Application (2025-2030)
Figure 66. Global Biopharmaceutical CMO and CRO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Biopharmaceutical CMO and CRO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biopharmaceutical CMO and CRO Market Size (M USD), 2019-2030
Figure 5. Global Biopharmaceutical CMO and CRO Market Size (M USD) (2019-2030)
Figure 6. Global Biopharmaceutical CMO and CRO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biopharmaceutical CMO and CRO Market Size by Country (M USD)
Figure 11. Biopharmaceutical CMO and CRO Sales Share by Manufacturers in 2023
Figure 12. Global Biopharmaceutical CMO and CRO Revenue Share by Manufacturers in 2023
Figure 13. Biopharmaceutical CMO and CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biopharmaceutical CMO and CRO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biopharmaceutical CMO and CRO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biopharmaceutical CMO and CRO Market Share by Type
Figure 18. Sales Market Share of Biopharmaceutical CMO and CRO by Type (2019-2024)
Figure 19. Sales Market Share of Biopharmaceutical CMO and CRO by Type in 2023
Figure 20. Market Size Share of Biopharmaceutical CMO and CRO by Type (2019-2024)
Figure 21. Market Size Market Share of Biopharmaceutical CMO and CRO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biopharmaceutical CMO and CRO Market Share by Application
Figure 24. Global Biopharmaceutical CMO and CRO Sales Market Share by Application (2019-2024)
Figure 25. Global Biopharmaceutical CMO and CRO Sales Market Share by Application in 2023
Figure 26. Global Biopharmaceutical CMO and CRO Market Share by Application (2019-2024)
Figure 27. Global Biopharmaceutical CMO and CRO Market Share by Application in 2023
Figure 28. Global Biopharmaceutical CMO and CRO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biopharmaceutical CMO and CRO Sales Market Share by Region (2019-2024)
Figure 30. North America Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biopharmaceutical CMO and CRO Sales Market Share by Country in 2023
Figure 32. U.S. Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biopharmaceutical CMO and CRO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biopharmaceutical CMO and CRO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biopharmaceutical CMO and CRO Sales Market Share by Country in 2023
Figure 37. Germany Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biopharmaceutical CMO and CRO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biopharmaceutical CMO and CRO Sales Market Share by Region in 2023
Figure 44. China Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biopharmaceutical CMO and CRO Sales and Growth Rate (K Units)
Figure 50. South America Biopharmaceutical CMO and CRO Sales Market Share by Country in 2023
Figure 51. Brazil Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biopharmaceutical CMO and CRO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biopharmaceutical CMO and CRO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biopharmaceutical CMO and CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biopharmaceutical CMO and CRO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biopharmaceutical CMO and CRO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biopharmaceutical CMO and CRO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biopharmaceutical CMO and CRO Market Share Forecast by Type (2025-2030)
Figure 65. Global Biopharmaceutical CMO and CRO Sales Forecast by Application (2025-2030)
Figure 66. Global Biopharmaceutical CMO and CRO Market Share Forecast by Application (2025-2030)
